BioPharmGuy logo
Sponsored By:
Project Management Now
Purchase the BioPharmGuy data
Sinclair Research
Senorx is defunct.

Fate: Acquired by Bard, May 2010, $200M


------------------
If you believe any of this information is incorrect, please let us know.